Skip to main content

Business

Comparing Medical Cost of Care for Patients with Metastatic Breast Cancer Receiving Taxane Therapy: Claims Analysis

Rex W. Force, PharmD, Brooke A. Pugmire, PharmD, Vaughn L. Culbertson, PharmD

Stakeholder Perspective

Can We Afford Improved Clinical Outcomes?

by Atheer A. Kaddis, PharmD

Comparing Pharmacy Benefit Managers: Moving Well Beyond the Simple Spreadsheet Analysis

David Calabrese, RPh, MHP

Stakeholder Perspective

Maximizing Savings, Efficiency, and Quality when Contracting with a PBM

by Thomas McCarter, MD, FACP

Business, Original Research

Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors

Rajeev Ayyagari, PhD, Maureen Neary, PhD, MS, Shang Li, MS, Ariel Rokito, BS, Hongbo Yang, PhD, Jipan Xie, MD, PhD, Al B. Benson III, MD, FACP, FASCO

Rajeev Ayyagari, PhD; Maureen Neary, PhD, MS; Shang Li, MS; Ariel Rokito, BS; Hongbo Yang, PhD; Jipan Xie, MD, PhD; Al B. Benson III, MD, FACP, FASCO

Business, Original Research

Comparing Treatment Persistence, Healthcare Resource Utilization, and Costs in Adult Patients with Major Depressive Disorder Treated with Escitalopram or Citalopram

Eric Q. Wu, PhD, Paul E. Greenberg, MA, Rym Ben-Hamadi, MSc, Andrew P. Yu, PhD, Elaine H. Yang, PhD, M. Haim Erder, PhD

Stakeholder Perspective

Efficacy and Cost-Effectiveness: Escitalopram versus Citalopram

by Matthew Mitchell, PharmD, MBA, FAMCP

Business, Original Research

Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients

Tia Goss Sawhney, DrPH, FSA, MAAA, Bruce S. Pyenson, FSA, MAAA, David Rotter, PhD, Michele Berrios, Judy Yee, MD

Tia Goss Sawhney, DrPH, FSA, MAAA; Bruce S. Pyenson, FSA, MAAA; David Rotter, PhD; Michele Berrios; Judy Yee, MD

Business, Original Research

Cost-Effectiveness of de novo Simvastatin as Adjunctive Therapy in Patients Critically Ill with Sepsis

Sara Mosta Eladawy, MSc, PhD, Mohamed Abd Alsalam Elgendy, MD, Mamdouh Ahmed Zaki, MD, Naglaa Samir Bazan, MSc, PhD

Sara Mostafa Eladawy, MSc, PhD; Mohamed Abd Alsalam Elgendy, MD; Mamdouh Ahmed Zaki, MD; Naglaa Samir Bazan, MSc, PhD

Cost-Effectiveness of Second-Generation Antihistamines and Montelukast in Relieving Allergic Rhinitis Nasal Symptoms

Michael J. Goodman, PhD, Mehul Jhaveri, PharmD, Kim Saverno, PhD, Kellie Meyer, PharmD, Brian Nightengale, PhD

Stakeholder Perspective

Relieving Nasal Symptoms: Uncommon Excellence in a Common Clinical Condition

by Michael F. Murphy, MD, PhD

Business, Original Research

Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models

Thomas Lodise, PhD, PharmD, Kenneth LaPensee, PhD, MPH

Thomas Lodise, PhD, PharmD; Kenneth LaPensee, PhD, MPH

Business, Original Research

Costs and Effectiveness of Mindfulness-Based Art Therapy versus Standard Breast Cancer Support Group for Women with Cancer

Katherine M. Prioli, MS, Laura T. Pizzi, PharmD, MPH, Kathryn M. Kash, PhD, Andrew B. Newberg, MD, Anna Marie Morlino, PharmD, Michael Matthews, BS, Daniel A. Monti, MD

Katherine M. Prioli, BS; Laura T. Pizzi, PharmD, MPH; Kathryn M. Kash, PhD; Andrew B. Newberg, MD; Anna Marie Morlino, PharmD; Michael J. Matthews, BS; Daniel A. Monti, MD

Stakeholder Perspective

Creative Therapeutic Activities and Support Groups Benefit All Those Involved in Cancer Care

Linda Bily, MA, CSA, OPN-CG

by Linda Bily, MA, CSA, OPN-CG

Business, Original Research

Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer

Krishna Tangirala, MPH, Sreevalsa Appukkuttan, MPH, MBBS, Stacey Simmons, MD

Krishna Tangirala, MPH; Sreevalsa Appukkuttan, MPH, MBBS; Stacey Simmons, MD

1
2
3
4
5
6
7

Page 4 of 16
Results 31 - 40 of 156